| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 09/11/2013 | CN103288716A Novel intermediate for preparing alvimopan, preparation method of novel intermediate and method for preparing alvimopan by using novel intermediate |
| 09/11/2013 | CN101151255B 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 09/10/2013 | US8530666 Copper-catalysed process for the production of substituted or unsubstituted trifluormethylated aryl and heteroaryl compounds |
| 09/10/2013 | US8530499 Glucokinase activators |
| 09/10/2013 | US8530472 Ethynyl derivatives |
| 09/10/2013 | US8530434 Nitroxide free radical synergized antineoplastic agents |
| 09/10/2013 | CA2611376C Therapeutic agents |
| 09/10/2013 | CA2579501C Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 09/06/2013 | WO2013130849A1 Substituted dioxopiperidinyl phthalimide derivatives |
| 09/06/2013 | WO2013130358A1 Macrocyclic compounds |
| 09/05/2013 | US20130231478 Novel Intermediate for Preparing Tapentadol or Analogues Thereof |
| 09/05/2013 | US20130231341 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 09/05/2013 | US20130231332 Small molecule inhibitors of ebola and lassa fever viruses and methods of use |
| 09/05/2013 | US20130231319 Bridged Spiro[2.4]heptane Ester Derivatives |
| 09/04/2013 | EP2632898A1 Heterocyclic tyrosine kinase inhibitors |
| 09/04/2013 | EP2632892A1 Diterpenoid derivatives endowed of biological properties |
| 09/04/2013 | CN103274995A Process for manufacturing polymerization inhibitor 708 |
| 09/04/2013 | CN103274994A Preparation method of 2, 2, 6, 6-tetramethyl-piperidinooxy stearate |
| 09/04/2013 | CN103274993A Novel synthesis method of dihydropyridine and pyrrole heterocyclic rings |
| 09/04/2013 | CN103274992A Method for preparing high-purity 1-deoxynojirimycin with combined membrane separation and column chromatography technology |
| 09/04/2013 | CN103274991A Method and device for producing 2, 2, 6, 6-Tetramethyl-4-piperidinol through continuous catalytic hydrogenation |
| 09/04/2013 | CN101784524B Ionic liquids |
| 09/04/2013 | CN101544596B Preferred crystal-form substance of nitrendipine and preparation method, pharmaceutical composition and application thereof |
| 09/03/2013 | US8524947 Acylsulfonamides and processes for producing the same |
| 09/03/2013 | US8524896 Chemical compounds |
| 09/03/2013 | US8524744 Arylamine ketones, their preparation methods, the pharmaceutical composition containing them and their use |
| 09/03/2013 | US8524711 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/03/2013 | US8524665 Use of secretin in treatments of disorders associated with the amygdala |
| 08/29/2013 | WO2013124335A1 Antiviral compounds |
| 08/29/2013 | US20130225825 Process for the preparation of tryptase inhibitors |
| 08/29/2013 | US20130225621 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat protein |
| 08/29/2013 | US20130225596 Novel heterocyclic derivative and pharmaceutical composition comprising the same (as amended) |
| 08/29/2013 | US20130225565 2,5-disubstituted arylsulfonamide ccr3 antagonists |
| 08/29/2013 | CA2857262A1 Antiviral compounds |
| 08/28/2013 | EP2629851A1 Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors |
| 08/28/2013 | CN1538951B Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells |
| 08/28/2013 | CN103270018A Calcium-sensing receptor-active compounds |
| 08/28/2013 | CN103265477A Aminoheteroaryl compounds as protein kinase inhibitors |
| 08/28/2013 | CN103265476A Azasugar quaternary ammonium salt compound and preparation method and application thereof |
| 08/28/2013 | CN102123986B Pharmaceutical compositions |
| 08/28/2013 | CN101712645B Preparation method for (2R, 4R)-4-substituted-2-piperidine carboxylic acid compound and intermediate thereof |
| 08/27/2013 | US8519158 Androgen receptor modulator compounds and methods |
| 08/27/2013 | US8519143 Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors |
| 08/27/2013 | US8519140 Method for synthesizing pirfenidone |
| 08/27/2013 | US8519139 Indazolamides with analgesic activity |
| 08/27/2013 | US8519138 Process for the preparation of a biphenyl-2-yl carbamic acid ester |
| 08/27/2013 | US8519137 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 08/27/2013 | US8519125 Compositions and methods for biological sample storage |
| 08/27/2013 | US8518934 Oxycarbamoyl compounds and the use thereof |
| 08/27/2013 | CA2599843C Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 08/27/2013 | CA2531868C Process for the preparation of thalidomide |
| 08/22/2013 | WO2013120911A1 Alkaline earth metal-complexed metal bisamides |
| 08/22/2013 | WO2013120878A1 Alkaline earth metal-complexed metal amides |
| 08/22/2013 | WO2013120874A1 Process for preparing chloroamines |
| 08/21/2013 | EP2627635A1 Salts of arylsulfonamide ccr3 antagonists |
| 08/21/2013 | CN103261159A Process for the preparation of imides, of derivatives thereof and uses |
| 08/21/2013 | CN103260703A Piperidin-4-yl-zetidine diamides as monoacylglycerol lipase inhibitors |
| 08/21/2013 | CN103254122A Preparation method of cardiovascular drug nilvadipine |
| 08/21/2013 | CN103254121A Synthesis method of (3R, 4R)-N-PG-4-methyl-3-methylaminopiperidine |
| 08/21/2013 | CN103254120A Spiro-azasugar quaternary ammonium salt compound, and preparation method and application thereof |
| 08/21/2013 | CN103254119A Inhibitors of sodium glucose co-transporter 2 and methods of their use |
| 08/21/2013 | CN101472891B Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain |
| 08/21/2013 | CN101421258B Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 08/20/2013 | US8513425 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof |
| 08/20/2013 | US8513422 Piperidine derivative |
| 08/20/2013 | US8513253 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors |
| 08/20/2013 | US8513237 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 08/20/2013 | US8513162 Halogen-containing organosulfur compound and use thereof |
| 08/20/2013 | CA2723302C Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 08/20/2013 | CA2606262C Novel histamine h3-receptor ligands and their therapeutic applications |
| 08/20/2013 | CA2591894C Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon2-yl)methyl] piperidine or its salt thereof via novel intermediate |
| 08/15/2013 | WO2013064703A3 Fkbp subtype-specific rapamycin analogue for use in treatment of diseases |
| 08/15/2013 | US20130211093 Process for the Preparation of 1-Hydroxy-6-Substituted Pyridones |
| 08/15/2013 | US20130210625 Spiroheterocyclic pyrrolidine derivatives based pesticides |
| 08/14/2013 | EP2625174A1 Co-crystals and salts of ccr3-inhibitors |
| 08/14/2013 | CN103249697A Deuterated analogs of pridopidine useful as dopaminergic stabilizers |
| 08/14/2013 | CN103242261A Synthetic method of alpha-amino aromatic ketone compound |
| 08/14/2013 | CN103242221A Preparation method of dihydropyridine compound |
| 08/14/2013 | CN103242220A Preparation method of clevidipine butyrate |
| 08/14/2013 | CN103242219A 2,6-diketone-piperazine (piperidine) type derivative and application thereof |
| 08/14/2013 | CN103242218A N-substituted pipecolic acid derivative, as well as preparation method and application thereof |
| 08/14/2013 | CN103242210A Mulin acetate containing substituted squaric acid and application thereof |
| 08/14/2013 | CN102659667B Synthetic method of fexofenadine intermediate |
| 08/14/2013 | CN101959859B Process for the manufacture of [phenylsulfanylphenyl]piperidines |
| 08/13/2013 | US8507536 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 08/13/2013 | US8507529 Methods of using a nitroxide antioxidant in cosmetic and dermatological compositions |
| 08/13/2013 | US8507528 2-alkyl-indazole compounds for the treatment of certain cns-related disorders |
| 08/13/2013 | CA2393141C Novel methods for the treatment and prevention of ileus |
| 08/08/2013 | WO2013116690A1 Acyl piperidine inhibitors of soluble epoxide hydrolase |
| 08/08/2013 | US20130204001 Process for producing compounds comprising nitrile functions |
| 08/08/2013 | US20130203815 Cytokine inhibitors |
| 08/08/2013 | US20130203757 Compounds And Compositions For Treating Cancer |
| 08/08/2013 | US20130203738 Use of compound binding to msin3b that specifically binds to neuron restrictive silencer factor (nrsf) |
| 08/08/2013 | US20130203734 Anti-inflammatory agents |
| 08/08/2013 | US20130203727 Napht-2-ylacetic acid derivatives to treat aids |
| 08/08/2013 | US20130203724 Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof |
| 08/08/2013 | US20130203709 Acylsulfonamides and processes for producing the same |
| 08/07/2013 | EP2623491A2 Piperidine and piperazine derivatives as autotaxin inhibitors |
| 08/07/2013 | CN103237788A Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 08/07/2013 | CN103232387A Tirofiban hydrochloride impurity, preparation method and detection method of impurity |